{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:34:33Z","timestamp":1793468073723,"version":"4.5.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.autrev.2023.103310","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T21:19:12Z","timestamp":1678396752000},"page":"103310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium"],"prefix":"10.1016","volume":"22","author":[{"given":"Ot\u00e1vio","family":"Cabral-Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusan","family":"Catar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Preu\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Bankamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Christin","family":"Pecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhild","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Kamalanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieke","family":"van Oostveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Hohberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Koolmoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivine","family":"Levarht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudmer","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"van Duinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton Jan","family":"van Zonneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeska","family":"de Vries-Bouwstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Fehres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Yuri Nery","family":"do Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla Batista","family":"da Silva Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Salerno","family":"Filgueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena F.","family":"Schimke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Crispim","family":"Baiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Cabral","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennyson Leandro Mathias","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Paccielli","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Hackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Grasshoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"St\u00e4hle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Dechend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Sotzny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Sakmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D.","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Schulze-Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heidecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Scheibenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103310_bb0005","series-title":"Proceedings of the Royal Society of London","first-page":"424","article-title":"Croonian lecture.\u2014On immunity with special reference to cell life","volume":"66","author":"Paul Erlich","year":"1900"},{"key":"10.1016\/j.autrev.2023.103310_bb0010","doi-asserted-by":"crossref","first-page":"A251","DOI":"10.1016\/j.autrev.2009.10.007","article-title":"Travels and travails of autoimmunity: a historical journey from discovery to rediscovery","volume":"9","author":"Mackay","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0015","first-page":"1590","article-title":"Uber paroxysmale h\u00e4moglobinurie","volume":"51","author":"Donath","year":"1904","journal-title":"M\u00fcnch Med Wochenschr"},{"key":"10.1016\/j.autrev.2023.103310_bb0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmj.2.5706.381","article-title":"Autoimmune haemolytic anaemias","volume":"2","author":"Dacie","year":"1970","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2023.103310_bb0025","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(46)90573-9","article-title":"Haemolytic icterus (acholuric jaundice) congenital and acquired","volume":"247","author":"Boorman","year":"1946","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103310_bb0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/ki.2010.237","article-title":"The rise and fall of horror autotoxicus and forbidden clones","volume":"78","author":"Jennette","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103310_bb0035","series-title":"The clonal selection theory of acquired immunity","author":"Burnet","year":"1959"},{"key":"10.1016\/j.autrev.2023.103310_bb0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(06)68125-7","article-title":"Autoimmune disease","volume":"367","author":"Parnes","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103310_bb0045","first-page":"1414","article-title":"Pathogenic antibodies","volume":"20","author":"Dempsey","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0050","first-page":"8","article-title":"Mechanisms of autoantibody-induced pathology","author":"Ludwig","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/cmi.2010.70","article-title":"Explosion of autoimmune diseases and the mosaic of old and novel factors","volume":"8","author":"Agmon-Levin","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature11896","article-title":"Molecular signatures of G-protein-coupled receptors","volume":"494","author":"Venkatakrishnan","year":"2013","journal-title":"Nature"},{"issue":"207","key":"10.1016\/j.autrev.2023.103310_bb0065","first-page":"1361","article-title":"Autoantibodies to \u03b22-adrenergic receptors: a possible cause of adrenergic Hyporesponsiveness in allergic rhinitis and asthma","volume":"1980","author":"Venter","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.autrev.2023.103310_bb0070","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2017.134","article-title":"Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases","volume":"13","author":"Cabral-Marques","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103310_bb0075","series-title":"1st Symposium on Functional Autoantibodies Targeting G-Protein-Coupled Receptors","year":"2016"},{"key":"10.1016\/j.autrev.2023.103310_bb0080","author":"Riemekasten"},{"key":"10.1016\/j.autrev.2023.103310_bb0085","author":"Riemekasten"},{"key":"10.1016\/j.autrev.2023.103310_bb0090","author":"Riemekasten"},{"key":"10.1016\/j.autrev.2023.103310_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221109404","article-title":"A broad look into the future of systemic sclerosis","volume":"14","author":"Riemekasten","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.autrev.2023.103310_bb0100","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.autrev.2016.03.005","article-title":"Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","volume":"15","author":"Cabral-Marques","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0105","article-title":"Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome","author":"Bankamp","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2023.103310_bb0110","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.autrev.2023.103310_bb0115","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","article-title":"Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study","volume":"2","author":"Webb","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2023.103310_bb0120","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109123118","article-title":"High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19","volume":"118","author":"Lourda","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/d41586-021-00149-1","article-title":"Rogue antibodies could be driving severe COVID-19","volume":"590","author":"Khamsi","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103310_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0135","first-page":"6","article-title":"Anti-body antibodies in COVID-19","author":"Lichtman","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102695","article-title":"SARS-CoV-2, the autoimmune virus","volume":"19","author":"Halpert","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0150","first-page":"370","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"2020","author":"Bastard","year":"1979","journal-title":"Science"},{"issue":"7866","key":"10.1016\/j.autrev.2023.103310_bb0155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103310_bb0160","series-title":"Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity","volume":"13","author":"Cabral-Marques","year":"2022"},{"key":"10.1016\/j.autrev.2023.103310_bb0165","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Cabral-Marques","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2023.103310_bb0170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115695119","article-title":"Autoreactive antibodies control blood glucose by regulating insulin homeostasis","volume":"119","author":"Amendt","year":"2022","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060726","article-title":"Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease","volume":"8","author":"Nagele","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2023.103310_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.it.2008.10.002","article-title":"Naturally occurring auto-antibodies in homeostasis and disease","volume":"30","author":"Lutz","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0185","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI14452","article-title":"Autoantibodies as predictors of disease","volume":"108","author":"Leslie","year":"2001","journal-title":"J Clin Investig"},{"key":"10.1016\/j.autrev.2023.103310_bb0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103310_bb0195","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41584-021-00608-z","article-title":"Systemic and organ-specific immune-related manifestations of COVID-19","volume":"17","author":"Ramos-Casals","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103310_bb0200","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.jaip.2021.06.046","article-title":"Association of Varying Clinical Manifestations and Positive Anti\u2013SARS-CoV-2 IgG antibodies: a cross-sectional observational study","volume":"9","author":"Silverberg","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.autrev.2023.103310_bb0205","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.2816","article-title":"SARS-CoV-2 Seroprevalence and symptom onset in culturally linked orthodox Jewish communities across multiple regions in the United States","volume":"4","author":"Zyskind","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.autrev.2023.103310_bb0210","series-title":"COVID-19 clinical management: living guidance","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.autrev.2023.103310_bb0215","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4049\/jimmunol.172.4.2697","article-title":"Breakdown of tolerance to a self-peptide of acetylcholine receptor \u03b1-subunit induces experimental myasthenia gravis in rats","volume":"172","author":"Baggi","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2020.100023","article-title":"Antibodies against group a Streptococcus, dopamine receptors, and ganglioside GM1 cross-react with a variety of food antigens, potentially interfering with biomarkers for PANS and PANDAS","volume":"3","author":"Vojdani","year":"2020","journal-title":"Biomark Neuropsychiatry"},{"key":"10.1016\/j.autrev.2023.103310_bb0225","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Cabral-Marques","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2023.103310_bb0230","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Https:\/\/Covid19WhoInt\/ n.d."},{"key":"10.1016\/j.autrev.2023.103310_bb0235","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41564-021-00932-w","article-title":"SARS-CoV-2 variants of interest and concern naming scheme conducive for global discourse","volume":"6","author":"Konings","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.autrev.2023.103310_bb0240","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/ijmm.2020.4659","article-title":"Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: diagnostic and therapeutic perspectives (review)","volume":"46","author":"Cavalli","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.autrev.2023.103310_bb0245","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.4049\/jimmunol.1102592","article-title":"Brain human monoclonal autoantibody from Sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease","volume":"191","author":"Cox","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1672568","article-title":"Amyloid-Beta 1-42 cross-reactive antibody prevalent in human sera may contribute to intraneuronal deposition of A-Beta-P-42","volume":"2018","author":"Vojdani","year":"2018","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.autrev.2023.103310_bb0255","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5056\/jnm.2012.18.1.78","article-title":"Anti-enteric neuronal antibodies and the irritable bowel syndrome","volume":"18","author":"Wood","year":"2012","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.autrev.2023.103310_bb0260","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1074\/jbc.270.8.4005","article-title":"The dopamine D1D receptor","volume":"270","author":"Demchyshyn","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2023.103310_bb0265","doi-asserted-by":"crossref","first-page":"00379","DOI":"10.1183\/23120541.00379-2022","article-title":"Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19","volume":"8","author":"Tran","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.autrev.2023.103310_bb0270","doi-asserted-by":"crossref","first-page":"11793","DOI":"10.3390\/ijms222111793","article-title":"Autoantibodies from patients with scleroderma renal crisis promote PAR-1 receptor activation and IL-6 production in endothelial cells","volume":"22","author":"Simon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0275","first-page":"13","article-title":"Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in post COVID syndrome correlate with symptom severity","author":"Sotzny","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0280","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2023.103310_bb0285","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","article-title":"A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity","volume":"13","author":"Kedor","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2023.103310_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28538","article-title":"Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity","author":"Baiocchi","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.autrev.2023.103310_bb0295","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome \u2013 evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0300","first-page":"12","article-title":"Epstein-Barr virus and the origin of Myalgic encephalomyelitis or chronic fatigue syndrome","author":"Ruiz-Pablos","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0305","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1386-6532(99)00079-7","article-title":"Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients","volume":"16","author":"Ablashi","year":"2000","journal-title":"J Clin Virol"},{"key":"10.1016\/j.autrev.2023.103310_bb0310","first-page":"209","article-title":"Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients","volume":"23","author":"Fr\u00e9mont","year":"2009","journal-title":"In Vivo"},{"key":"10.1016\/j.autrev.2023.103310_bb0315","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI118990","article-title":"Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome","volume":"98","author":"Konstantinov","year":"1996","journal-title":"J Clin Investig"},{"key":"10.1016\/j.autrev.2023.103310_bb0320","first-page":"21","article-title":"High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders","volume":"1","author":"Klein","year":"1995","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.autrev.2023.103310_bb0325","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to \u03b2 adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2023.103310_bb0330","article-title":"Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic encephalomyelitis (ME) patients \u2013 a validation study in plasma and cerebrospinal fluid from two Swedish cohorts","volume":"7","author":"Bynke","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.autrev.2023.103310_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102527","article-title":"A unifying hypothesis of the pathophysiology of Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): recognitions from the finding of autoantibodies against \u00df2-adrenergic receptors","volume":"19","author":"Wirth","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0340","article-title":"IgG stimulated \u03b22 adrenergic receptor activation is attenuated in patients with ME\/CFS","volume":"3","author":"Hartwig","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.autrev.2023.103310_bb0345","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.12.2.225","article-title":"Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome","author":"Tanaka","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.autrev.2023.103310_bb0350","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/jon.12751","article-title":"Altered structural brain networks related to adrenergic\/muscarinic receptor autoantibodies in chronic fatigue syndrome","volume":"30","author":"Fujii","year":"2020","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.autrev.2023.103310_bb0355","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.3390\/jcm10163675","article-title":"Autoantibodies to Vasoregulative G-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"10","author":"Freitag","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2023.103310_bb0360","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/jcm9082443","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: efficacy of repeat Immunoadsorption","volume":"9","author":"T\u00f6lle","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2023.103310_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129898","article-title":"B-lymphocyte depletion in Myalgic encephalopathy\/ chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment","volume":"10","author":"Fluge","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2023.103310_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193672","article-title":"Immunoadsorption to remove \u00df2 adrenergic receptor antibodies in chronic fatigue syndrome CFS\/ME","volume":"13","author":"Scheibenbogen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2023.103310_bb0375","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"Pr\u00fcss","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0380","first-page":"10","article-title":"Autoimmune diseases and psychotic disorders","author":"Jeppesen","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.autrev.2023.103310_bb0385","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41537-021-00143-6","article-title":"DNA hydrolysing IgG catalytic antibodies: an emerging link between psychoses and autoimmunity","volume":"7","author":"Ramesh","year":"2021","journal-title":"NPJ Schizophr"},{"key":"10.1016\/j.autrev.2023.103310_bb0390","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.autrev.2023.103310_bb0395","series-title":"Alzheimer Disease","author":"Kumar","year":"2022"},{"key":"10.1016\/j.autrev.2023.103310_bb0400","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-170245","article-title":"Antibodies to signaling molecules and receptors in Alzheimer\u2019s disease are associated with psychomotor slowing, depression, and poor visuospatial function","volume":"59","author":"Giil","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.autrev.2023.103310_bb0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-018-0284-2","article-title":"Peripheral immune system in aging and Alzheimer\u2019s disease","volume":"13","author":"Cao","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.autrev.2023.103310_bb0410","doi-asserted-by":"crossref","first-page":"26716","DOI":"10.18632\/oncotarget.5777","article-title":"Serotonin 6 receptor controls alzheimer\u2019s disease and depression","volume":"6","author":"Yun","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2023.103310_bb0415","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3233\/JAD-150053","article-title":"Autoantibodies toward the angiotensin 2 type 1 receptor: a novel autoantibody in Alzheimer\u2019s disease","volume":"47","author":"Giil","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.autrev.2023.103310_bb0420","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/cmi.2008.43","article-title":"Vascular damages in rats immunized by \u03b11-adrenoceptor peptides","volume":"5","author":"Zhou","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0425","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10286-020-00714-0","article-title":"The extended autonomic system, dyshomeostasis, and COVID-19","volume":"30","author":"Goldstein","year":"2020","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.autrev.2023.103310_bb0430","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s12265-020-10031-6","article-title":"Implications for neuromodulation therapy to control inflammation and related organ dysfunction in COVID-19","volume":"13","author":"Fudim","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.autrev.2023.103310_bb0435","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1172\/JCI139642","article-title":"Preventing cytokine storm syndrome in COVID-19 using \u03b1-1 adrenergic receptor antagonists","volume":"130","author":"Konig","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.autrev.2023.103310_bb0440","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-018-0774-y","article-title":"Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome","volume":"564","author":"Staedtke","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103310_bb0445","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-8707(68)90117-2","article-title":"The beta adrenergic theory of the atopic abnormality in bronchial asthma","volume":"42","author":"Szentivanyi","year":"1968","journal-title":"J Allergy (Cairo)"},{"key":"10.1016\/j.autrev.2023.103310_bb0450","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0928-0197(98)00011-7","article-title":"Coxsackie B virus infection and \u03b2 cell autoantibodies in newly diagnosed IDDM adult patients","volume":"9","author":"Andr\u00e9oletti","year":"1998","journal-title":"Clin Diagn Virol"},{"key":"10.1016\/j.autrev.2023.103310_bb0455","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000335965","article-title":"Effect of ischemia duration on autoantibody response in rats undergoing retinal ischemia-reperfusion","volume":"48","author":"Joachim","year":"2012","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.autrev.2023.103310_bb0460","first-page":"9","article-title":"Agonistic autoantibodies to the \u03b22-adrenergic receptor involved in the pathogenesis of open-angle Glaucoma","author":"J\u00fcnemann","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0465","first-page":"9","article-title":"Agonistic autoantibodies to the \u03b22-adrenergic receptor involved in the pathogenesis of open-angle Glaucoma","author":"J\u00fcnemann","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0470","first-page":"10","article-title":"Autoantibodies activating the \u03b22-adrenergic receptor characterize patients with primary and secondary Glaucoma","author":"Hohberger","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0475","first-page":"12","article-title":"Agonistic \u03b22-adrenergic receptor autoantibodies characterize the aqueous humor of patients with primary and secondary open-angle Glaucoma","author":"Hohberger","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0480","first-page":"772","article-title":"Beta-adrenergic receptors in human trabecular meshwork. Identification and autoradiographic localization","volume":"28","author":"Jampel","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0485","first-page":"420","article-title":"Distribution and properties of beta-adrenergic receptors in human iris-ciliary body","volume":"28","author":"Wax","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0490","article-title":"Influence of agonistic \u03b22-adrenergic receptor autoantibodies on retinal capillary flow in ocular hypertension and open-angle Glaucoma","volume":"56","author":"Hohberger","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0495","article-title":"OCT-angiography: agonistic \u03b22-adrenergic receptor autoantibodies and FAZ-to-FAZ-ratio in glaucoma patients","volume":"60","author":"Mardin","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272811","article-title":"Glaucoma and Alzheimer: neurodegenerative disorders show an adrenergic dysbalance","volume":"17","author":"Hohberger","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2023.103310_bb0505","article-title":"Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms","volume":"4","author":"Wallukat","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.autrev.2023.103310_bb0510","first-page":"8","article-title":"Retinal microcirculation as a correlate of a systemic capillary impairment after severe acute respiratory syndrome coronavirus 2 infection","author":"Hohberger","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103310_bb0515","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.bpj.2021.05.025","article-title":"Physical phenotype of blood cells is altered in COVID-19","volume":"120","author":"Kub\u00e1nkov\u00e1","year":"2021","journal-title":"Biophys J"},{"key":"10.1016\/j.autrev.2023.103310_bb0520","first-page":"8","article-title":"Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection","author":"Hohberger","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103310_bb0525","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/TP.0b013e3182529bb7","article-title":"Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies","volume":"94","author":"Lukitsch","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2023.103310_bb0530","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.3390\/ijms23137209","article-title":"Long COVID: Association of Functional Autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation","volume":"23","author":"Szewczykowski","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0535","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCRESAHA.121.319994","article-title":"Immune pathways in etiology, acute phase, and chronic sequelae of ischemic stroke","volume":"130","author":"Endres","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2023.103310_bb0540","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1747-4949.2012.00871.x","article-title":"Prediction of vascular risk after stroke \u2014 protocol and pilot data of the prospective cohort with incident stroke (PROSCIS)","volume":"8","author":"Liman","year":"2013","journal-title":"Int J Stroke"},{"key":"10.1016\/j.autrev.2023.103310_bb0545","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.3390\/ijms15023003","article-title":"Recent progress in understanding subtype specific regulation of NMDA receptors by G protein coupled receptors (GPCRs)","volume":"15","author":"Yang","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0550","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/STROKEAHA.119.026100","article-title":"Serum anti-NMDA (N-methyl-D-aspartate)-receptor antibodies and long-term clinical outcome after stroke (PROSCIS-B)","volume":"50","author":"Sperber","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.autrev.2023.103310_bb0555","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1007\/s00415-022-11203-x","article-title":"Serum anti-NMDA-receptor antibodies and cognitive function after ischemic stroke (PROSCIS-B)","volume":"269","author":"Sperber","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2023.103310_bb0560","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bbamem.2006.12.006","article-title":"G protein-coupled receptors control NMDARs and metaplasticity in the hippocampus","volume":"1768","author":"MacDonald","year":"2007","journal-title":"Biochim Biophys Acta (BBA) - Biomembr"},{"key":"10.1016\/j.autrev.2023.103310_bb0565","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti- N -methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2023.103310_bb0570","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acn3.120","article-title":"High prevalence of NMDA receptor IgA\/IgM antibodies in different dementia types","volume":"1","author":"Doss","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2023.103310_bb0575","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/STROKEAHA.114.008323","article-title":"Preexisting serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke","volume":"46","author":"Zerche","year":"2015","journal-title":"Stroke"},{"issue":"287","key":"10.1016\/j.autrev.2023.103310_bb0580","first-page":"1453","article-title":"An Oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy","volume":"2000","author":"During","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.autrev.2023.103310_bb0585","first-page":"13","article-title":"Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis\/chronic fatigue syndrome","author":"Gravelsina","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108384","article-title":"Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy","volume":"214","author":"Shoenfeld","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0595","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/biom12060776","article-title":"Cognitive impairment, sleep disturbance, and depression in women with silicone breast implants: association with autoantibodies against autonomic nervous system receptors","volume":"12","author":"Tocut","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.autrev.2023.103310_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103230","volume":"22","author":"Malkova","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0605","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/diagnostics13010066","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome and post-COVID syndrome: a common Neuroimmune ground?","volume":"13","author":"Ryabkova","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.autrev.2023.103310_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102631","article-title":"Autoimmune dysautonomia in women with silicone breast implants","volume":"120","author":"Halpert","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103310_bb0615","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/ije\/dyy217","article-title":"Silicone breast implants and the risk of autoimmune\/rheumatic disorders: a real-world analysis","volume":"47","author":"Watad","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.autrev.2023.103310_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103218","article-title":"The biology of symptom-based disorders \u2013 time to act","volume":"22","author":"Goebel","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0625","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.3390\/ijms20205164","article-title":"Neuroimmunology: what role for autoimmunity, neuroinflammation, and small fiber neuropathy in fibromyalgia, chronic fatigue syndrome, and adverse events after human papillomavirus vaccination?","volume":"20","author":"Ryabkova","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109039","article-title":"Intravenouse immunoglobuline in dysautonomia","volume":"240","author":"Gavrilova","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0635","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103310_bb0640","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-170245","article-title":"Antibodies to signaling molecules and receptors in Alzheimer\u2019s disease are associated with psychomotor slowing, depression, and poor visuospatial function","volume":"59","author":"Giil","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.autrev.2023.103310_bb0645","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molimm.2020.12.027","article-title":"Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren\u2019s syndrome","volume":"131","author":"Yue","year":"2021","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0650","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1\u2013receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103310_bb0655","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/cei.12324","article-title":"A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients\u2019 sera","volume":"177","author":"Preuss","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0660","first-page":"5","article-title":"Multiplexed analysis of the secretin-like GPCR-RAMP interactome","author":"Lorenzen","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.autrev.2023.103310_bb0665","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/pmic.201500398","article-title":"Multiplexed protein profiling by sequential affinity capture","volume":"16","author":"Ayoglu","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.autrev.2023.103310_bb0670","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A human protein atlas for Normal and Cancer tissues based on antibody proteomics","volume":"4","author":"Uhl\u00e9n","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.autrev.2023.103310_bb0675","first-page":"S634","article-title":"Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes","volume":"46","author":"Wallukat","year":"1987","journal-title":"Biomed Biochim Acta"},{"key":"10.1016\/j.autrev.2023.103310_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1474-8673.1993.tb00394.x","article-title":"Supersensitivity to \u03b2-adrenoceptor stimulation evoked in cultured neonatal rat heart myocytes by L(+)-lactate and pyruvate","volume":"13","author":"Wallukat","year":"1993","journal-title":"J Auton Pharmacol"},{"key":"10.1016\/j.autrev.2023.103310_bb0685","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2016-000199","article-title":"Mouse models of lupus: what they tell us and what they don\u2019t","volume":"5","author":"Richard","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2023.103310_bb0690","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.2741\/4689","article-title":"Autoantibodies against muscarinic acetylcholine receptor M sub 3 sub in Sjogren rsquo s syndrome and corresponding mouse models","volume":"23","author":"Yu","year":"2018","journal-title":"Front Biosci"},{"key":"10.1016\/j.autrev.2023.103310_bb0695","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.autrev.2018.03.001","article-title":"A methodological review of induced animal models of autoimmune diseases","volume":"17","author":"Yu","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103310_bb0700","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12016-011-8288-5","article-title":"Animal models in autoimmune diseases: lessons learned from mouse models for Sj\u00f6gren\u2019s syndrome","volume":"42","author":"Lee","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0705","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020241","article-title":"Mouse models of human autoimmune diseases: essential tools that require the proper controls","volume":"2","author":"Morel","year":"2004","journal-title":"PLoS Biol"},{"key":"10.1016\/j.autrev.2023.103310_bb0710","doi-asserted-by":"crossref","first-page":"16642","DOI":"10.1038\/s41598-017-16999-7","article-title":"A novel human systemic lupus erythematosus model in humanised mice","volume":"7","author":"Gunawan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103310_bb0715","first-page":"10","article-title":"Humanized mouse models of rheumatoid arthritis for studies on Immunopathogenesis and preclinical testing of cell-based therapies","author":"Schinnerling","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0720","first-page":"12","article-title":"Transfer of PBMC from SSc patients induces autoantibodies and systemic inflammation in Rag2-\/-\/IL2rg-\/- mice","author":"Yue","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0725","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103310_bb0730","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13075-022-02896-6","article-title":"Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc","volume":"24","author":"Shu","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103310_bb0735","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/annrheumdis-2021-222088","article-title":"Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching","volume":"81","author":"Yue","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103310_bb0740","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.42748.x","article-title":"Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sj\u00f6gren\u2019s syndrome","volume":"104","author":"Bacman","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0745","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1\u2013receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103310_bb0750","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1160\/TH08-10-0710","article-title":"Autoimmune mediated G-protein receptor activation in cardiovascular and renal pathologies","volume":"101","author":"Dragun","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2023.103310_bb0755","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.humimm.2012.07.010","article-title":"Non-HLA-antibodies targeting angiotensin type 1 receptor and antibody mediated rejection","volume":"73","author":"Dragun","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0760","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/MOT.0b013e328355f12b","article-title":"Role of non-HLA antibodies in organ transplantation","volume":"17","author":"Dragun","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.autrev.2023.103310_bb0765","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MOT.0b013e3283636e55","article-title":"Non-HLA antibodies in solid organ transplantation","volume":"18","author":"Dragun","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.autrev.2023.103310_bb0770","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.kint.2016.03.019","article-title":"Non-HLA antibodies against endothelial targets bridging Allo- and autoimmunity","volume":"90","author":"Dragun","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103310_bb0775","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.transproceed.2021.01.013","article-title":"Non-HLA autoantibodies at 1 year negatively affect 5-year native renal function in liver transplant recipients","volume":"53","author":"O\u2019Leary","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.autrev.2023.103310_bb0780","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/ijms23010244","article-title":"Autoantibodies targeting AT1- and ETA-receptors link endothelial proliferation and coagulation via Ets-1 transcription factor","volume":"23","author":"Catar","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0785","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.kint.2021.09.029","article-title":"Non-HLA antibodies targeting angiotensin II type 1 receptor and endothelin-1 type a receptors induce endothelial injury via \u03b22-arrestin link to mTOR pathway","volume":"101","author":"Catar","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103310_bb0790","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.3390\/ijms23073984","article-title":"Molecular effects of auto-antibodies on angiotensin II type 1 receptor signaling and cell proliferation","volume":"23","author":"Philippe","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0795","first-page":"13","article-title":"Angiotensin and endothelin receptor structures with implications for signaling regulation and pharmacological targeting","author":"Speck","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103310_bb0800","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/jcm11030833","article-title":"Non-HLA antibodies in hand transplant recipients are connected to multiple acute rejection episodes and endothelial activation","volume":"11","author":"Sikorska","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2023.103310_bb0805","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/cells10040910","article-title":"Transcriptional regulation of thrombin-induced endothelial VEGF induction and proangiogenic response","volume":"10","author":"Catar","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2023.103310_bb0810","first-page":"13","article-title":"Antigen and cell-based assays for the detection of non-HLA antibodies","author":"Lammerts","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0815","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2017.134","article-title":"Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases","volume":"13","author":"Cabral-Marques","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103310_bb0820","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41577-021-00513-2","article-title":"Targeting autoantibodies in COVID-19","volume":"21","author":"Pedroza-Pacheco","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0825","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/0961203310365715","article-title":"Clinical and molecular evidence for association of SLE with parvovirus B19","volume":"19","author":"Pavlovic","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2023.103310_bb0830","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","article-title":"Hepatitis B virus (HBV) and autoimmune disease","volume":"34","author":"Maya","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2023.103310_bb0835","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1196\/annals.1422.059","article-title":"Epstein Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report","volume":"1108","author":"Barzilai","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2023.103310_bb0840","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.2741\/4707","article-title":"Loss of balance in normal GPCR-mediated cell trafficking","volume":"24","author":"Riemekasten","year":"2019","journal-title":"Front Biosci"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:29:48Z","timestamp":1761600588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":168,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1568997223000447"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103310","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103310"}}